Back to

Nils Peters

Partner, Zurich
Supports pharma and medical device companies with a broad range of challenges, from developing portfolio strategies and analytics and digital strategies to designing go-to-market models and managing post-merger integration

About Nils

Nils is a partner in our Zurich office and one of the leaders of our med tech and biotech work in Europe. Since joining McKinsey in 2009, he has worked extensively across the medical devices industry from big-box equipment to consumables, as well as supporting clients in the specialty pharma and biotech sectors globally.

Nils has advised leading institutions on a wide range of topics, from go-to-market strategies and marketing spend optimization to business development and commercial transformation. His recent client projects include:

  • Supporting a rare-disease specialist company with key account management and patient finding
  • Advising several biotech and big pharma companies on inorganic growth strategies
  • Working on a number of post-merger commercial integrations for large specialty pharma and medical device companies
  • Helping a major pharma company with its corporate-level digital and analytics strategy
  • Counseling med tech companies on the development of cross-business services and solutions in cardiology, critical care, and orthopedics.

Nils holds a doctorate in strategic, supply chain, and innovation management from the University of St Gallen and a master’s degree in strategic management, finance, and operations from the University of Karlsruhe. Before joining McKinsey, he spent four years as a postdoctoral research fellow at the University of St Gallen working on innovation and sustainability strategies in consumer goods, chemicals, and pharma companies.

Published work

From extreme to mainstream: The future of aesthetics injectables,” McKinsey & Company, December 2021

A call to action: Opportunities and challenges for CGTs in Europe,” McKinsey & Company, January 2021

Ready for launch: Reshaping pharma’s strategy in the next normal,” McKinsey & Company, December 2020

Improving healthcare while curbing cost: Med-tech companies offer a solution,” McKinsey & Company, October 2015


University of St Gallen
Doctorate in strategic, supply chain, and technology innovation management

University of Karlsruhe
MA, strategic management, finance, and operations